Ulrich Frank Pape

Summary

Affiliation: Humboldt University
Country: Germany

Publications

  1. doi request reprint Management of follow-up of neuroendocrine neoplasias
    Ulrich Frank Pape
    Medical Department, Division of Hepatology and Gastroenterology, Charité Campus Mitte and Virchow Klinikum, Charite University Medicine Berlin, Germany Electronic address
    Best Pract Res Clin Endocrinol Metab 30:129-40. 2016
  2. ncbi request reprint Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a german referral center
    Ulrich Frank Pape
    Department of Internal Medicine, Charite Universitatsmedizin Berlin, Campus Virchow Klinikum, Medical Faculty of the Humboldt University, Berlin, Germany
    Ann N Y Acad Sci 1014:222-33. 2004
  3. doi request reprint Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors
    Ulrich Frank Pape
    Department of Hepatology and Gastroenterology, Chariteé Campus Virchow Clinic, Berlin University of Medicine, Berlin, Germany
    Cancer 113:256-65. 2008
  4. doi request reprint Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours
    Ulrich Frank Pape
    Department of Hepatology and Gastroenterology, Charite, Campus Virchow Klinikum, University Medicine Berlin, Berlin, Germany
    Endocr Relat Cancer 15:1083-97. 2008
  5. doi request reprint Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours
    Nils F Schreiter
    Department of Nuclear Medicine, Charite Universitatsmedizin Berlin, Berlin, Germany
    Eur J Nucl Med Mol Imaging 39:72-82. 2012
  6. ncbi request reprint Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa Study
    Siegbert Faiss
    Universitatsklinikum Charite, Campus Virchow Klinikum, Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Augustenburger Platz 1, D 13353 Berlin, Germany
    J Clin Oncol 21:2689-96. 2003
  7. doi request reprint Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome
    Henning Jann
    Department of Hepatology and Gastroenterology, Charite, Campus Virchow Klinikum, University Medicine Berlin, Berlin, Germany
    Cancer 117:3332-41. 2011
  8. doi request reprint Role of (68)Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study
    Vikas Prasad
    Department of Nuclear Medicine, Charite Universitatsmedizin Berlin, Berlin, Germany
    Eur J Nucl Med Mol Imaging 43:1593-600. 2016
  9. doi request reprint Impact of Ga-68 DOTATOC PET/CT on the diagnosis and treatment of patients with multiple endocrine neoplasia
    Vera Froeling
    Department of Radiology, Charite, Universitatsmedizin Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany
    Ann Nucl Med 26:738-43. 2012
  10. ncbi request reprint Malnutrition Predicts Clinical Outcome in Patients with Neuroendocrine Neoplasia
    Sebastian Maasberg
    Department of Hepatology and Gastroenterology, Campus Charité Mitte and Campus Virchow Klinikum, Charite Universitatsmedizin Berlin, Berlin, Germany
    Neuroendocrinology 104:11-25. 2017

Collaborators

Detail Information

Publications23

  1. doi request reprint Management of follow-up of neuroendocrine neoplasias
    Ulrich Frank Pape
    Medical Department, Division of Hepatology and Gastroenterology, Charité Campus Mitte and Virchow Klinikum, Charite University Medicine Berlin, Germany Electronic address
    Best Pract Res Clin Endocrinol Metab 30:129-40. 2016
    ..Follow-up shall serve the patient to improve outcome, benefit from more effective therapies and suffer less from unnecessary and/or toxic therapeutic interventions and finally preserve or gain a good quality of life. ..
  2. ncbi request reprint Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a german referral center
    Ulrich Frank Pape
    Department of Internal Medicine, Charite Universitatsmedizin Berlin, Campus Virchow Klinikum, Medical Faculty of the Humboldt University, Berlin, Germany
    Ann N Y Acad Sci 1014:222-33. 2004
    ..7% of successfully resected patients. Palliative medical treatment, either with chemotherapy (i.e., especially for foregut NETs) or biotherapy (especially for midgut NETs), was only moderately effective for both therapeutic regimens...
  3. doi request reprint Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors
    Ulrich Frank Pape
    Department of Hepatology and Gastroenterology, Chariteé Campus Virchow Clinic, Berlin University of Medicine, Berlin, Germany
    Cancer 113:256-65. 2008
    ..In 2006, a new TNM classification system was proposed for the staging and grading of upper GEP NETs...
  4. doi request reprint Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours
    Ulrich Frank Pape
    Department of Hepatology and Gastroenterology, Charite, Campus Virchow Klinikum, University Medicine Berlin, Berlin, Germany
    Endocr Relat Cancer 15:1083-97. 2008
    ....
  5. doi request reprint Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours
    Nils F Schreiter
    Department of Nuclear Medicine, Charite Universitatsmedizin Berlin, Berlin, Germany
    Eur J Nucl Med Mol Imaging 39:72-82. 2012
    ..The aim of this study was to compare the costs for the two diagnostic tests and the respective consequential costs...
  6. ncbi request reprint Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa Study
    Siegbert Faiss
    Universitatsklinikum Charite, Campus Virchow Klinikum, Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Augustenburger Platz 1, D 13353 Berlin, Germany
    J Clin Oncol 21:2689-96. 2003
    ..Until now, however, no prospective, randomized studies in therapy-naive patients have compared somatostatin analogs or interferon alfa alone with a combination of the two...
  7. doi request reprint Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome
    Henning Jann
    Department of Hepatology and Gastroenterology, Charite, Campus Virchow Klinikum, University Medicine Berlin, Berlin, Germany
    Cancer 117:3332-41. 2011
    ..The purpose of this study was to test the efficacy of a proposal for TNM staging and grading for midgut and hindgut NETs...
  8. doi request reprint Role of (68)Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study
    Vikas Prasad
    Department of Nuclear Medicine, Charite Universitatsmedizin Berlin, Berlin, Germany
    Eur J Nucl Med Mol Imaging 43:1593-600. 2016
    ..To explore the role of (68)Ga-DOTATATE/DOTATOC PET/CT (SR PET/CT) in patients with suspicion of or histopathologically proven pancreatogenic hyperinsulinaemic hypoglycaemia...
  9. doi request reprint Impact of Ga-68 DOTATOC PET/CT on the diagnosis and treatment of patients with multiple endocrine neoplasia
    Vera Froeling
    Department of Radiology, Charite, Universitatsmedizin Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany
    Ann Nucl Med 26:738-43. 2012
    ..To evaluate the impact of Ga-68 DOTATOC PET/CT on diagnosis and therapeutic management of patients with multiple endocrine neoplasia (MEN)...
  10. ncbi request reprint Malnutrition Predicts Clinical Outcome in Patients with Neuroendocrine Neoplasia
    Sebastian Maasberg
    Department of Hepatology and Gastroenterology, Campus Charité Mitte and Campus Virchow Klinikum, Charite Universitatsmedizin Berlin, Berlin, Germany
    Neuroendocrinology 104:11-25. 2017
    ....
  11. doi request reprint Streptozocin/5-fluorouracil chemotherapy is associated with durable response in patients with advanced pancreatic neuroendocrine tumours
    Lisa Marie Dilz
    Dept of Hepatology and Gastroenterology, Campus Virchow Klinikum, Charite Universitatsmedizin Berlin, Germany
    Eur J Cancer 51:1253-62. 2015
    ..However, the sequence of treatment remains unclear. We aimed to evaluate the efficacy of STZ plus 5-fluorouracil (STZ/5-FU) in a large pNET cohort...
  12. ncbi request reprint Increased Activity of the Immunoregulatory Enzyme Indoleamine-2,3-Dioxygenase (IDO) with Consecutive Tryptophan Depletion Predicts Death in Patients with Neuroendocrine Neoplasia
    Rene Pschowski
    Department of Hepatology and Gastroenterology, Charitx00E9 Campus Mitte CCM and Campus Virchow Clinic CVK, Charitx00E9, University Medicine Berlin, Berlin, Germany
    Neuroendocrinology . 2016
    ..Here we investigate the predictive value of the activity of IDO as well as levels of tryptophan and respective downstream catabolites in a large cohort of patients with neuroendocrine neoplasia (NEN)...
  13. ncbi request reprint From basic to clinical research in gastroenteropancreatic neuroendocrine tumor disease -- the clinician-scientist perspective
    Bertram Wiedenmann
    Department of Internal Medicine, Division of Hepatology and Gastroenterology, Interdisciplinary Center of Metabolism and Endocrinology, Charite, Campus Virchow Hospital, University Medicine Berlin, Berlin, Germany
    Neuroendocrinology 80:94-8. 2004
    ..As well, new therapeutic treatment options translated from current findings in the fields of molecular and tumor biology are discussed...
  14. doi request reprint Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours
    Nils F Schreiter
    Department of Nuclear Medicine, Charite, Augustenburger Platz 1, 13353 Berlin, Germany
    Eur Radiol 22:458-67. 2012
    ..This study was performed to assess the role of retrospective PET-MRI fusion with Ga-68-DOTA(0)-Phe(1)-Tyr(3)-octreotide (Ga-68-DOTATOC) PET and Gd-EOB-DTPA MRI in the detection of hepatic metastases from neuroendocrine tumours (NET)...
  15. doi request reprint Staged Catheter-Based Valve Treatment of Severe Carcinoid Heart Disease
    Michael Laule
    Department of Cardiology and Angiology, Campus Mitte, Charitx00E9 University Medicine Berlin, Berlin, Germany
    Neuroendocrinology 103:259-62. 2016
    ..In this paper, we present a novel interventional treatment approach and report the first clinical result achieved in a patient with extensive CHD...
  16. doi request reprint Waitlist characteristics of patients at a single-center intestinal and multivisceral transplant program
    Undine A Gerlach
    Department of General, Visceral, and Transplantation Surgery, Charite Universitaetsmedizin Berlin, Berlin, Germany
    Transpl Int 26:392-401. 2013
    ..MVTX-candidates have a high waitlist mortality for different reasons. However, the current allocation policy for MVTX does not mirror the severity of disease and may therefore contribute to high waitlist mortality...
  17. ncbi request reprint Influence of attenuation correction by integrated low-dose CT on somatostatin receptor SPECT
    Juri Ruf
    Klinik fur Strahlenheilkunde, Charite, Centrum 6 für diagnostische und interventionelle Radiologie und Nuklearmedizin, Charite Universitatsmedizin Berlin, Germany
    Nucl Med Commun 28:782-8. 2007
    ..Somatostatin receptor scintigraphy (SRS) is well-established in neuroendocrine tumour (NET) imaging. This study evaluated the impact of attenuation correction (AC) on SRS SPECT data in patients examined by SPECT-CT...
  18. doi request reprint Pharmacological strategies to enhance adaptation in intestinal failure
    Ulrich Frank Pape
    aMedical Department, Division of Hepatology and Gastroenterology bDepartment of General, Visceral, and Transplantation Surgery, Charité Campus Mitte and Virchow Klinikum, Charite University Medicine Berlin, Berlin, Germany
    Curr Opin Organ Transplant 21:147-52. 2016
    ..Parenteral nutrition, although lifesaving, is associated with short and long-term complications as well as with reduced quality of life and overall survival...
  19. doi request reprint Magnetic resonance enteroclysis in patients with Crohn's disease: fat saturated T2-weighted sequences for evaluation of inflammatory activity
    Christian Grieser
    Klinik für Radiologie, Campus Virchow Klinikum, Charite Universitatsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
    J Crohns Colitis 6:294-301. 2012
    ..To evaluate fat saturated (fs) T2-weighted (w) fast relaxation fast spin echo (FRFSE)-sequences compared to the standard protocol with contrast agent for the evaluation of inflammatory activity in patients with Crohn's Disease (CD)...
  20. doi request reprint Tissue-infiltrating plasma cells are an important source of carboxylesterase 2 contributing to the therapeutic efficacy of prodrugs
    Anja A Kuhl
    Medical Department, Division of Gastroenterology, Infectiology and Rheumatology Research Center ImmunoSciences, Campus Benjamin Franklin, Charite Universitatsmedizin Berlin, Germany
    Cancer Lett 378:51-8. 2016
    ..We here demonstrated plasma cells as strong producers of CES-2. Further studies should elucidate the role of CES-2(+) plasma cells in intestinal inflammation and cancer. ..
  21. ncbi request reprint Fatal embolic myocardial infarction after systemic thrombolysis for stroke
    Wassilios Meissner
    Department of Neurology, Charite Campus Virchow Klinikum, Humboldt University Berlin, Berlin, Germany
    Cerebrovasc Dis 22:213-4. 2006
  22. doi request reprint Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells
    Andreas Fischer
    Department of Medicine, Division of Gastroenterology and Hepatology, Humboldt University of Berlin, Berlin, Germany
    Am J Physiol Gastrointest Liver Physiol 304:G970-9. 2013
    ..Barrier protection might therefore constitute a novel mechanism how anti-TNF-α therapy contributes to epithelial restitution and tissue repair in inflammatory bowel diseases...
  23. doi request reprint Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group
    Anja Rinke
    Department of Internal Medicine, Division of Gastroenterology and Endocrinology, Institute of Medical Biometry and Epidemiology, Philipps University, Marburg, Germany
    J Clin Oncol 27:4656-63. 2009
    ..We performed a placebo-controlled, double-blind, phase IIIB study in patients with well-differentiated metastatic midgut NETs. The hypothesis was that octreotide LAR prolongs time to tumor progression and survival...